Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice.
Information Mitsubishi Chemical Group ― Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
February 16, 2023
The parent company of Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka, Japan; Representative Director: Hiroaki Ueno), Mitsubishi Chemical Group Corporation (Head office: Chiyoda-ku, Tokyo; President: Jean-Marc Gilson) made the following announcement today.
Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
URL:https://www.mcgc.com/english/news_release/pdf/01494/01730.pdf
- Related information